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The emerging clinical importance of staphylococcal
infections prompted us to establish a reference database
for partial RNA polymerase B (rpoB; nucleotides 1444–
1928) gene sequences from type strains of all staphylococ-
cal species and subspecies. This database correctly identi-
fied 55 clinical staphylococcal isolates; all were correctly
identified at the species level. At the subspecies level, rpoB
misidentified only 2 isolates.
T
he emerging clinical importance of Staphylococcus
aureus and coagulase-negative staphylococci (1) in
connection with the expanding number of staphylococcal
subspecies described requires accurate identification to the
subspecies level. Currently, the genus Staphylococcus is
divided into 36 species and 21 subspecies. Staphylococcal
subspecies not included in the databases of commercial
identification systems, as well as phenotypic variants (e.g.,
small-colony variants), are often misidentified (2). 
We recently described the usefulness of genotypic iden-
tification of staphylococcal subspecies by using partial
16S rDNA sequences in comparison with phenotypic tests
(3). However, the partial 16S rDNA sequences used were
not discriminative enough to differentiate all staphylococ-
cal subspecies. When searching for a molecular target for
discrimination of staphylococci, several genes have been
evaluated, e.g., heat shock protein 60 (hsp60) (4), superox-
ide dismutase A(sodA) (5), and RNApolymerase B (rpoB)
(6). However, these studies concentrated only on a limited
number of staphylococcal species. Therefore, a complete
reference database of partial rpoB gene sequences from
type strains (n = 47) and other culture collection strains,
including all validly described staphylococcal subspecies,
was created for this study. This reference database was
then evaluated with clinical isolates. Results were com-
pared with those previously obtained by 16S rDNA
sequencing and conventional phenotypic tests.
The Study
We analyzed 82 type and other culture collection strains
encompassing all validly described staphylococcal species
(n = 38) and subspecies (n = 21; according to the current
List of Bacterial Names with Standing in Nomenclature,
updated May 14, 2005) (7). Two strains of the recently pro-
posed candidate species S. pettenkoferi (8) were added to
complete the rpoB sequence reference database. Using this
database, we analyzed 55 clinical staphylococcal isolates
collected from human (n = 52) and animal (S. intermedius,
n = 2; S. felis, n = 1) specimens; 6 of the human isolates
exhibited the small-colony variant (SCV) phenotype. 
This strain collection was previously analyzed by the
API ID 32 Staph and VITEK 2 systems (both obtained
from bioMérieux, Marcy l’Etoile, France), partial 16S
rDNA sequencing, chemotaxonomy, and riboprinting to
determine species designation (3). The thermal cycling
condition to amplify the partial rpoB gene (899 bp) was 35
cycles of denaturation at 94°C for 45 s (300 s for the first
cycle), annealing (60 s at 52°C), and extension (90 s at
72°C, 600 s for the last cycle). The Staphylococcus-
specific primers used for amplification and sequencing of
rpoB are shown in Table 1. Sequencing reactions were per-
formed in a total volume of 10 µL containing 0.5 µL pre-
mix (ABI Prism BigDye Terminator v3.0 Ready Reaction
Cycle Sequencing Kit, Applied Biosystems, Darmstadt,
Germany), 1.8 µL 400 mmol/L Tris-HCl, 10 mmol/L
MgCl2, 10 pmol sequencing primer, and 2 µL polymerase
chain reaction product. The sequencing products were
purified by using the Centri-Sep Spin Columns (Princeton
Separations, Adelphia, NJ, USA) and analyzed with the
ABI Prism 3100 Avant Genetic Analyzer (Applied
Biosystems) according to the manufacturer’s instructions.
For further analysis, nucleotides 1444–1928 (correspon-
ding to S. aureus rpoB gene positions of the GenBank
accession no. X64172) of the rpoB gene were used. The
sequences were analyzed by using Ridom TraceEditPro
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Germany). Staphylococcal partial rpoB reference
sequences determined in this study were deposited in
GenBank under accession nos. DQ120729–DQ120752.
Partial rpoB sequences were determined for 82 culture
collection strains and 55 clinical isolates. All staphylococ-
cal type strains were distinguishable by rpoB; the only
exception was the S. equorum subspecies that shared the
same sequence (online Appendix Figure, available from
http://www.cdc.gov/ncidod/EID/vol12no02/05-0962_
G.htm). The mean pairwise distance of all type and other
culture collection strains exhibiting a unique rpoB
sequence (n = 68) was 13.7% (range 0%–21.4%) and the
standard deviation was 3.3%. When assuming a normal
distribution for the distances and choosing a reporting cri-
terion >94.0%, the similarity for a distinct species corre-
lates with a statistical error probability of 1.0% (9). 
The definitive identification of 55 clinical isolates and
the rpoB gene sequence similarity search results are shown
in Table 2. At the species level, the correct species desig-
nation for all 55 clinical isolates was made by rpoB
sequence similarity search (sequence similarity >94.0%).
Of 21 clinical isolates belonging to species currently divid-
ed into subspecies, 17 isolates were correctly identified to
the subspecies level. Subspecies identification for isolates
M26 and M53 was unsuccessful by rpoB or partial 16S
rDNAsequencing, riboprinting, and chemotaxonomy (data
not shown). Only isolates M20 and M39 were misidenti-
fied by rpoB sequencing as S. saprophyticus subsp. sapro-
phyticus instead of subsp. bovis. 
Conclusions
Our previous study demonstrated the superiority of
sequence-based methods over phenotypic approaches
using the API ID 32 Staph and VITEK 2 systems (3). The
advantage of a sequence-based method became most evi-
dent when differentiating isolates with the SCVphenotype,
in which the API ID 32 Staph and VITEK 2 systems
misidentified 2 and 4 isolates, respectively. When both
sequence-based approaches used were compared, rpoB
sequencing was superior to partial 16S rDNA identifica-
tion. Although the 16S rDNA procedure differentiated 50
(90.9%) of all tested clinical isolates at species level, rpoB
identified 100%. Therefore, if an unknown organism needs
to be identified, 16S rDNA sequencing is the method of
choice because of the availability of universal primers
(10). However, if the genus is already known, the rpoB
method should be used.
Compared with other published molecular probes, rpoB
showed the highest discriminatory power, e.g., hsp60 and
sodA sequencing did not differentiate subspecies of S.
carnosus, S. cohnii, S. hominis, S. schleiferi, or S. succinus
(4,5). In a previous study, rpoB sequence-based identifica-
tion of Staphylococcus species has been reported (6).
However, a limited number of taxa were included, and the
primers used were not appropriate to detect all staphylo-
coccal subspecies. 
Sequencing of rpoB was also used to identify other bac-
terial species (11,12). A higher discrimination with rpoB
sequencing compared with 16S rDNA sequencing has
been demonstrated for the genera Corynebacterium (13)
and Bacillus (14). DNAsequencing is a rapid alternative to
biochemical and other phenotypic procedures for the dif-
ferentiation of bacterial pathogens because of its decreased
costs and increased automation (15). Thus, rpoB is a use-
ful molecular target for differentiating staphylococcal iso-
lates to the species and subspecies level.
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Use of trade names is for identification only and does not imply
endorsement by the Public Health Service or by the U.S.
Department of Health and Human Services.
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